These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 19996143)

  • 21. Harmonisation of resistance monitoring programmes in veterinary medicine: an urgent need in the EU?
    Silley P; de Jong A; Simjee S; Thomas V
    Int J Antimicrob Agents; 2011 Jun; 37(6):504-12. PubMed ID: 21295449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. European standards for antibiotic susceptibility testing: towards a theoretical consensus.
    Baquero F
    Eur J Clin Microbiol Infect Dis; 1990 Jul; 9(7):492-5. PubMed ID: 2226478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Alexander Project: the benefits from a decade of surveillance.
    Felmingham D; White AR; Jacobs MR; Appelbaum PC; Poupard J; Miller LA; Grüneberg RN
    J Antimicrob Chemother; 2005 Oct; 56 Suppl 2():ii3-ii21. PubMed ID: 16282278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial resistance: action by laboratories today for a cure tomorrow.
    Kanungo R
    Indian J Med Microbiol; 2011; 29(3):205-6. PubMed ID: 21860096
    [No Abstract]   [Full Text] [Related]  

  • 25. [Layout proposal for a microtitre plate to be used in routine antimicrobial susceptibility testing of bacteria from infections of dogs and cats].
    Werckenthin C; Luhofer G; Böttner A; Gangl A; Goossens L; Hafez HM; Hartmann K; Kaske M; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Richter A; Schulz B; Schwarz S; Sigge C; Traeder W; Waldmann KH; Jürgen W; ;
    Berl Munch Tierarztl Wochenschr; 2008; 121(1-2):19-26. PubMed ID: 18277776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance testing of meningococci: the recommendations of the European Monitoring Group on Meningococci.
    Vázquez JA
    FEMS Microbiol Rev; 2007 Jan; 31(1):97-100. PubMed ID: 17147689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe.
    Brown D; Canton R; Dubreuil L; Gatermann S; Giske C; MacGowan A; Martinez-Martinez L; Mouton J; Skov R; Steinbakk M; Walton C; Heuer O; Struelens MJ; Diaz Hogberg L; Kahlmeter G
    Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Proposals of the working group "Antibiotic resistance" for the configuration of microtitre plates to be used in routine antimicrobial susceptibility testing of bacterial pathogens from infections of large food-producing animals and mastitis cases].
    Luhofer G; Böttner A; Hafez HM; Kaske M; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Richter A; Sigge C; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; Schwarz S;
    Berl Munch Tierarztl Wochenschr; 2004; 117(7-8):245-51. PubMed ID: 15298050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proposed disc zone breakpoints for doripenem for use with the BSAC disc susceptibility testing method.
    Hope R; Pllana T; Warner M; Livermore DM
    J Antimicrob Chemother; 2010 Jul; 65(7):1547-8. PubMed ID: 20483980
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing.
    Olsson-Liljequist B; Larsson P; Walder M; Miörner H
    Scand J Infect Dis Suppl; 1997; 105():13-23. PubMed ID: 9435027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCAST.
    Brown DF; Wootton M; Howe RA
    J Antimicrob Chemother; 2016 Jan; 71(1):3-5. PubMed ID: 26377864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms.
    Jorgensen JH; Ferraro MJ
    Clin Infect Dis; 2000 May; 30(5):799-808. PubMed ID: 10816150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach.
    Blondeau JM
    Vet Dermatol; 2009 Oct; 20(5-6):383-96. PubMed ID: 20178475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility tests and their role in therapeutic drug monitoring.
    DeGirolami PC; Eliopoulos G
    Clin Lab Med; 1987 Sep; 7(3):499-512. PubMed ID: 3308291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility testing of nonsporing anaerobes to ten antimicrobial agents.
    Rao PS; Shivananda PG
    Indian J Pathol Microbiol; 2000 Apr; 43(2):139-42. PubMed ID: 11217270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should we reevaluate antibiotic breakpoints?
    Ferraro MJ
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S227-9. PubMed ID: 11524723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Replace the testing of minimal inhibitory concentration with resistance testing?].
    Reisinger E
    Dtsch Med Wochenschr; 2009 Jul; 134(30):1542. PubMed ID: 19603374
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of interlaboratory variability on antimicrobial susceptibility determination.
    Annis DH; Craig BA
    Diagn Microbiol Infect Dis; 2005 Sep; 53(1):61-4. PubMed ID: 16182077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance and future of antimicrobial surveillance studies.
    Masterton R
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S21-31. PubMed ID: 18713046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility testing versus in vivo effectiveness.
    Stratton CW
    Med Clin North Am; 2006 Nov; 90(6):1077-88. PubMed ID: 17116437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.